Orders are available for pick-up at Restaurant Nicholas at 160 Route 35 South Red Bank, NJ 07701 during the following times:
Monday: 9:30-3:30; Tuesday – Friday: 9:15am – 9:00pm; Saturday: 11:00am – 9:00pm; Sunday: Closed
$60.00 $42.00
11/15/21 Note: I just saw that the Salvestrin 2018 Dr. Crane was put into the Top 10 wines of the year by Wine Spectator. I of course didn’t know that was going to happen before I got this wine for us, but it doesn’t surprise me. I only have less than two cases of the 2019 Napa Valley Cab up for grabs. First come, first served.
Dr. George Belden Crane was among the first visionaries to plant vines in the U.S. back in 1862. He made the sobering discovery that he would later document in his medical journal that there was far more money to be made in wine grapes than in medicine. If only he could have been around to see what his grapes fetch today!
Eventually, Ed Salvestrin’s family would go on to buy the Crane property in 1932. He and his wife, Suzanne would sell the fruit to the high-flying big name players in wine, such as the Beckstoffers (who purchased the vineyard in 1999), Paul Hobbs, Alpha Omega and Realm just to name a few. By the late 90’s prices had already began to swell into the $200-$300 range, with Dr. Crane Vineyard fruit commanding far more per ton than almost any other vineyard in the valley.
But like many of the best wines in the worlds, the Salvestrins finally decided to make their own Dr. Crane Vineyard Cabernet and bottle it under the family name. Ever since their inaugural vintage in 2001, they have become managed to stay a bit under the radar while consistently garnering big scores from arguably the world’s two toughest critics in Wine Spectator and Parker’s Wine Advocate.
While reviewing the 2010s, Robert Parker, Jr. himself declared, “These wines never seem to get old, and this will be one our grandchildren can enjoy circa 2050.”
Out of stock
Don't worry! Enter your email and we'll notify you when it's available again or if we have very similar products from this producer.
*Soon to be Rated*
Only logged in customers who have purchased this product may leave a review.
93 Points, Robert Parker’s Wine Advocate – 93 Points, Jeb Dunnuck
“Vignon’s 2019 Chateauneuf du Pape delivers even more than I hoped for based on a previous sample. Hints of garrigue, roses, cherries and raspberries appear on the nose, while the palate is full-bodied, silky and long, with an intense, almost briny finish. The assemblage is 50% Grenache, 10% each Mourvèdre and Syrah, plus smaller proportions of seven other permitted varieties, while the élevage includes foudres, demi-muids, concrete and wooden tanks, plus terracotta amphorae.”
90 Points, Robert Parker’s Wine Advocate
Xavier Vignon’s brand spanking new CDR 100% is a thing of beauty. It’s already got a blessing from Robert Parker’s Wine Advocate who described this wine as, “Full-bodied, concentrated and supple”. This is a gorgeous and intricate blend that features all of the Southern Rhone appellations. This year, the blend was 40% Grenache, 25% Mourvedre, 15% Syrah, 7% Cinsault, 7% Marselan, 6% Terret Noir. Nobody can do it like the mad scientist, Xavier Vignon.
The 2021 Napa Valley East side Cuvee is an instant classic. From the first whiff to the moment it hits the lips, its clear that this is a fabulously concentrated, serious wine: black in color, and featuring aromas of cassis, cedar and chocolate-tinged purple fruit. The mouthfeel is plush and voluptuous with a firm, solid finish that speaks to its potential for considerable aging.
Winemaker Pascal Sirat consistently puts out some of the best value Bordeaux in the region but he may have outdone himself in what was a stellar 2019 vintage throughout the region. Just south of Pomerol, the vines at Panchille borrow deep in the soil. The resulting wines are ripe but fresh, with an aromatic complexity and stony finish usually reserved for wine twice the price. Daniel Boulud tells me it’s been the hottest bottle of wine at Bar Boulud for over a month, so I figured I’d better hurry up and secure my allocation! Don’t miss it.
Reviews
There are no reviews yet.